Body mass index does not impact on molecular response rate of chronic myeloid leukaemia patients treated frontline with second generation tyrosine kinase inhibitors.
Matteo MolicaMartina CanichellaGioia ColafigliRoberto LatagliataDaniela DiverioGiuliana AlimenaRobin FoàMassimo BrecciaPublished in: British journal of haematology (2017)